Tags

Type your tag names separated by a space and hit enter

Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016.

Abstract

CDC has updated its interim guidelines for U.S. health care providers caring for pregnant women during a Zika virus outbreak (1). Updated guidelines include a new recommendation to offer serologic testing to asymptomatic pregnant women (women who do not report clinical illness consistent with Zika virus disease) who have traveled to areas with ongoing Zika virus transmission. Testing can be offered 2-12 weeks after pregnant women return from travel. This update also expands guidance to women who reside in areas with ongoing Zika virus transmission, and includes recommendations for screening, testing, and management of pregnant women and recommendations for counseling women of reproductive age (15-44 years). Pregnant women who reside in areas with ongoing Zika virus transmission have an ongoing risk for infection throughout their pregnancy. For pregnant women with clinical illness consistent with Zika virus disease,* testing is recommended during the first week of illness. For asymptomatic pregnant women residing in areas with ongoing Zika virus transmission, testing is recommended at the initiation of prenatal care with follow-up testing mid-second trimester. Local health officials should determine when to implement testing of asymptomatic pregnant women based on information about levels of Zika virus transmission and laboratory capacity. Health care providers should discuss reproductive life plans, including pregnancy intention and timing, with women of reproductive age in the context of the potential risks associated with Zika virus infection.

Links

  • FREE Publisher Full Text
  • Authors

    , , , , , , , , , , , , , , ,

    Source

    MeSH

    Adolescent
    Adult
    Centers for Disease Control and Prevention (U.S.)
    Diagnostic Tests, Routine
    Disease Outbreaks
    Female
    Health Personnel
    Humans
    Practice Guidelines as Topic
    Pregnancy
    Pregnancy Complications, Infectious
    Residence Characteristics
    Travel
    United States
    Young Adult
    Zika Virus Infection

    Pub Type(s)

    Journal Article

    Language

    eng

    PubMed ID

    26866840

    Citation

    Oduyebo, Titilope, et al. "Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age With Possible Zika Virus Exposure - United States, 2016." MMWR. Morbidity and Mortality Weekly Report, vol. 65, no. 5, 2016, pp. 122-7.
    Oduyebo T, Petersen EE, Rasmussen SA, et al. Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(5):122-7.
    Oduyebo, T., Petersen, E. E., Rasmussen, S. A., Mead, P. S., Meaney-Delman, D., Renquist, C. M., ... Jamieson, D. J. (2016). Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR. Morbidity and Mortality Weekly Report, 65(5), pp. 122-7. doi:10.15585/mmwr.mm6505e2.
    Oduyebo T, et al. Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age With Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep. 2016 Feb 12;65(5):122-7. PubMed PMID: 26866840.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. AU - Oduyebo,Titilope, AU - Petersen,Emily E, AU - Rasmussen,Sonja A, AU - Mead,Paul S, AU - Meaney-Delman,Dana, AU - Renquist,Christina M, AU - Ellington,Sascha R, AU - Fischer,Marc, AU - Staples,J Erin, AU - Powers,Ann M, AU - Villanueva,Julie, AU - Galang,Romeo R, AU - Dieke,Ada, AU - Muñoz,Jorge L, AU - Honein,Margaret A, AU - Jamieson,Denise J, Y1 - 2016/02/12/ PY - 2016/2/12/entrez PY - 2016/2/13/pubmed PY - 2016/6/14/medline SP - 122 EP - 7 JF - MMWR. Morbidity and mortality weekly report JO - MMWR Morb. Mortal. Wkly. Rep. VL - 65 IS - 5 N2 - CDC has updated its interim guidelines for U.S. health care providers caring for pregnant women during a Zika virus outbreak (1). Updated guidelines include a new recommendation to offer serologic testing to asymptomatic pregnant women (women who do not report clinical illness consistent with Zika virus disease) who have traveled to areas with ongoing Zika virus transmission. Testing can be offered 2-12 weeks after pregnant women return from travel. This update also expands guidance to women who reside in areas with ongoing Zika virus transmission, and includes recommendations for screening, testing, and management of pregnant women and recommendations for counseling women of reproductive age (15-44 years). Pregnant women who reside in areas with ongoing Zika virus transmission have an ongoing risk for infection throughout their pregnancy. For pregnant women with clinical illness consistent with Zika virus disease,* testing is recommended during the first week of illness. For asymptomatic pregnant women residing in areas with ongoing Zika virus transmission, testing is recommended at the initiation of prenatal care with follow-up testing mid-second trimester. Local health officials should determine when to implement testing of asymptomatic pregnant women based on information about levels of Zika virus transmission and laboratory capacity. Health care providers should discuss reproductive life plans, including pregnancy intention and timing, with women of reproductive age in the context of the potential risks associated with Zika virus infection. SN - 1545-861X UR - https://www.unboundmedicine.com/medline/citation/26866840/Update:_Interim_Guidelines_for_Health_Care_Providers_Caring_for_Pregnant_Women_and_Women_of_Reproductive_Age_with_Possible_Zika_Virus_Exposure___United_States_2016_ L2 - https://dx.doi.org/10.15585/mmwr.mm6505e2 DB - PRIME DP - Unbound Medicine ER -